Glutathione and GST Expression in Ovarian Cancer Response to Carboplatin
Author Information
Author(s): S Ghazal-Aswad, L Hogarth, AG Hall, M George, DP Sinha, M Lind, AH Calvert, JP Sunter, DR Newell
Primary Institution: University of Newcastle-upon-Tyne
Hypothesis
The study aims to define the relationship between tumour GSH concentration, GST isoenzyme expression, and response to carboplatin in epithelial ovarian cancer.
Conclusion
There was no association between the concentration of GSH or expression of GST isoenzymes and response to single agent carboplatin in primary previously untreated epithelial ovarian cancer.
Supporting Evidence
- Mean GSH concentrations were measured for patients who achieved complete response, partial response, static disease, or progressive disease.
- Statistical analysis showed no significant relationship between GSH concentration and response.
- GST isoenzyme expression was assessed and also showed no significant relationship with response.
Takeaway
The study looked at how certain chemicals in tumors affect how well ovarian cancer patients respond to a drug called carboplatin, and found that they don't really affect the response.
Methodology
Tumour samples from 39 patients were analyzed for GSH content and GST expression, and response was assessed after six courses of carboplatin therapy.
Limitations
The study only looked at intrinsic resistance and did not assess acquired resistance after chemotherapy.
Participant Demographics
Patients with advanced epithelial ovarian cancer stages Ic-IV.
Statistical Information
P-Value
0.32
Statistical Significance
p=0.32
Want to read the original?
Access the complete publication on the publisher's website